Wesana Health Appoints Meghna A. Gaeta as Chief Marketing Officer
Wesana Health Holdings Inc. (CSE: WESA; OTCQB: WSNAF) has appointed Meghna A. Gaeta as Chief Marketing Officer to lead its marketing strategy. Gaeta, with over 18 years of experience in healthcare and technology marketing, aims to bridge the gap between patients and providers, enhancing Wesana's position in mental health care delivery. The company has also engaged North Equities for investor communications, paying $70,000 in restricted stock units. These strategic moves are expected to bolster Wesana's clinical network and market presence.
- Appointment of Meghna A. Gaeta as CMO expected to enhance Wesana's marketing strategy.
- Gaeta brings 18 years of experience, improving prospects for brand innovation.
- Engagement of North Equities for investor communications may enhance market awareness.
- Concerns about continuity and experience gaps with new leadership.
- Potential risks associated with the nature of forward-looking statements regarding future partnerships and research.
CHICAGO and TORONTO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (“Wesana” or the “Company”) (CSE: WESA; OTCQB: WSNAF), a data-driven life sciences company focused on developing the novel therapies of tomorrow and delivering new care paradigms today, announced the appointment of Meghna A. Gaeta as Chief Marketing Officer. In this role, she will lead Wesana’s business marketing strategy.
“Meghna has a proven track record of brand innovation and development strategies,” said Daniel Carcillo, Founder and CEO of Wesana. “As Wesana continues to expand its clinical network, Meghna’s expertise in practice growth and technology driven patient experiences will help to position Wesana as a premiere leader in the mental health care delivery space. We are thrilled to leverage her ability to bridge the gap that too often exists between patients and their care providers.”
Meghna brings more than 18 years of experience in healthcare, operations, and technology marketing for major, consumer-facing brands, such as Twitter and Walgreens. Meghna most recently led a boutique marketing consultancy, working closely with healthcare, retail & start-up tech clients. In this role, she championed innovative technology to increase access to health care and led and developed scaled ecommerce strategies and solutions. Previously, she served as the head of retail marketing, global business marketing & strategy for Twitter. She also played a pivotal role in establishing and growing a first-of-its-kind care model at Walgreens. There she supervised marketing efforts for 100 retail (pilot) clinics at Walgreens drugstores in over 10 major US markets.
“Wesana is at the forefront of transforming mental health services and drug development and doing it in a way that centers the patient experience from start to finish,” said Gaeta. “Having been a long-time advocate for improved mental health services, I see this new opportunity with Wesana as a space where we can take the lead in assuring patients that there is hope for them and that new therapies are coming soon that can help alleviate the pain they are suffering from. I’m looking forward to building on Wesana’s existing success and helping pave the path to effective and more accessible mental health care.”
Meghna holds a Master of Science Degree in Marketing Communications & eCommerce from IIT Stuart School of Business as well as a Bachelor’s Degree in Political Science from Bryn Mawr College. She is currently working toward a Master of Marriage and Family Therapy degree from The Chicago School of Professional Psychology.
Wesana also announces it has retained the services of North Equities, an investor communications and public relations company, to assist the Company to enhance its market awareness, and communications strategy. Under the terms of the North Equities engagement, which is for an initial six-month period, North Equities will be paid US
About Wesana Health
Wesana Health helps people transcend barriers in mental health and performance. We innovate in care development through our therapies and patent-pending protocols, and in care delivery through activating a new multidisciplinary, technology-supported clinical model. Learn more at www.wesanahealth.com.
Forward-Looking Information and Statements
This news release contains “forward-looking information” within the meaning of applicable securities laws relating to future partnerships, collaborative research and the focus of the Company’s business. Any such forward-looking statements may be identified by words such as “expects”, “anticipates”, “intends”, “contemplates”, “believes”, “projects”, “plans” and similar expressions. Readers are cautioned not to place undue reliance on forward-looking statements. These statements should not be read as guarantees of future performance or results. Such statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements to be materially different from those implied by such statements. Although such statements are based on management’s reasonable assumptions, there can be no assurance regarding the participation in, or success of, partnerships or collaborative research or that the Company will continue its business as described above. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances or actual results unless required by applicable law. Readers are encouraged to refer to the Listing Statement filed on Company’s profile on SEDAR at www.sedar.com for information as to the risks and other factors which may affect the Company’s business objectives and strategic plans.
For more information, please contact:
Media Contact:
Izzy Forman
VP, Communications
Email: media@wesanahealth.com
Nick Opich / Annie Graf
KCSA Strategic Communications
Email: Wesana@kcsa.com
Phone: 212-896-1206 / 786-390-2644
On behalf of the Board of Directors:
Daniel Carcillo, Chief Executive Officer
Phone: (773) 236-7972
FAQ
What is the significance of Meghna A. Gaeta's appointment as CMO for WSNAF?
How will the engagement with North Equities impact WSNAF?
What background does Meghna A. Gaeta bring to Wesana Health?
What are the potential risks mentioned in Wesana's press release?
